(S)-N-(6-ethyl-2-((4aS,5aR)-5a-methyl-1,4,4a,5,5a,6-hexahydrocyclopropa[f]indazol-3-yl)-1H-benzo[d]imidazol-5-yl)-N-methyl-2-morpholinopropanamide

ID: ALA5082562

PubChem CID: 156494843

Max Phase: Preclinical

Molecular Formula: C26H34N6O2

Molecular Weight: 462.60

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1cc2[nH]c(-c3n[nH]c4c3C[C@@H]3C[C@]3(C)C4)nc2cc1N(C)C(=O)[C@H](C)N1CCOCC1

Standard InChI:  InChI=1S/C26H34N6O2/c1-5-16-10-19-20(12-22(16)31(4)25(33)15(2)32-6-8-34-9-7-32)28-24(27-19)23-18-11-17-13-26(17,3)14-21(18)29-30-23/h10,12,15,17H,5-9,11,13-14H2,1-4H3,(H,27,28)(H,29,30)/t15-,17+,26+/m0/s1

Standard InChI Key:  LQWZPLSKUZGYJN-IRRNSTBUSA-N

Molfile:  

 
     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
   14.4659   -9.1666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4659   -9.9879    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.1753  -10.3924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8847   -9.9879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8847   -9.1666    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1753   -8.7497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5978   -8.7559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3084   -9.1707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0214   -8.7601    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3060   -9.9920    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7321   -9.1749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0238   -7.9388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7283   -9.9972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4381  -10.4078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4415   -8.7647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1478   -9.1757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1490   -9.9979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9316  -10.2495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4156   -9.5828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9296   -8.9177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0149  -10.4030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2366   -9.5769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5018   -9.1663    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.7200   -8.9110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5030   -9.9877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7233  -10.2391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5501  -11.0361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1094  -10.5293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9374  -11.3320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1626  -11.5886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7707  -12.1297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7493  -12.2950    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   24.6437  -11.7420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5915   -7.9367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0096  -11.2202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  9 11  1  0
  9 12  1  0
 11 13  2  0
 13 14  1  0
 14 17  2  0
 16 15  2  0
 15 11  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 13 21  1  0
 22 26  1  0
 25 23  1  0
 23 24  1  0
 24 22  2  0
 19 22  1  0
 25 26  2  0
 25 28  1  0
 26 27  1  0
 27 30  1  0
 29 28  1  0
 30 29  1  0
 31 30  1  0
 29 31  1  0
 30 32  1  6
 29 33  1  6
  7 34  1  1
 21 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5082562

    ---

Associated Targets(Human)

ITK Tclin Tyrosine-protein kinase ITK/TSK (3699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IL2 Tchem Interleukin-2 (144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 462.60Molecular Weight (Monoisotopic): 462.2743AlogP: 3.32#Rotatable Bonds: 5
Polar Surface Area: 90.14Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.41CX Basic pKa: 5.50CX LogP: 3.46CX LogD: 3.45
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.61Np Likeness Score: -0.82

References

1. Abdel-Magid AF..  (2021)  Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases.,  12  (12.0): [PMID:34917248] [10.1021/acsmedchemlett.1c00619]

Source